Explore a little further

Collaboration

Stories and perspectives from Daytrade News.

From Daytrade News

12 stories shown · Newest added
Daytrade News

Moderna Stock Soars Over 90% in Premarket After Phase 3 Trial Success

Moderna's stock experienced a significant increase of more than 90% in premarket trading after the company announced positive results from a Phase 3 trial of its personalized mRNA cancer vaccine in collaboration with Merck. The trial demonstrated improvements in recurrence-free…

More perspectives

Across our publications

A selection of related stories